Furin通过内体转运途径调节APP降解并参与阿尔茨海默病
批准号:
81971030
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
陈国俊
依托单位:
学科分类:
意识障碍与认知功能障碍
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
陈国俊
中文摘要
Furin是一种来往于内体(endosome)和高尔基体的前体蛋白转化酶。Furin由于影响ADAM10和BDNF的功能,因而与阿尔茨海默病(Alzheimer Disease, AD)关系密切。前期实验发现,Furin过表达的细胞中APP和Abeta水平降低而自噬标记物LC3II水平增高;抑制ADAM10后Furin仍然能促进APP降解。而沉默AP2M1(内吞相关蛋白)或vps34(内体循环蛋白)后, Furin对APP的降解明显抑制。我们推测Furin具有新功能:即通过内体转运途径调节APP降解和Abeta水平。为此,我们将利用分子和细胞生物学以及furin条件敲除等手段研究:(1)在离体细胞中证实内体转运相关蛋白参与了Furin对APP降解调节;(2)在furin条件敲除鼠中验证APP内体转运途径的改变参与了AD病理改变及学习记忆障碍;并探索敲除鼠对神经元发育和可塑性的影响。
英文摘要
Furin is a pro-protein convertase that is trafficked between endosome and trans-Golgi networks. The substrates of Furin include ADAM10 and BDNF, which are closely associated with Alzheimer Disease (AD). However, our preliminary study has shown that Furin overexpression reduced APP protein and Abeta levels with the concomitant elevation of autophagic marker LC3II protein levels; and the effect of Furin on APP degradation could not be blocked by ADAM10 inhibitor. We further found that Furin-mediated APP degradation was largely prevented in cells with the silencing of adaptor protein AP2M1 or endosomal trafficking-related protein Vps34. We speculate that Furin might have novel roles in APP processing by regulating the endosomal trafficking. Therefore, using cellular and molecular methods and furin conditional knockout mice, we aimed to (1) Verify that Furin regulates endosomal trafficking of APP through AP2M1- and Vps34-associated mechanisms in vitro; (2) In furin conditional knockout mice, validate that Furin-mediated regulation of endosomal trafficking of APP is associated with pathological alterations of AD. Meanwhile, dissect the potential mechanisms of the alterations of synaptic plasticity by Furin knockout.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
DOI:
10.1016/j.neulet.2023.137265
发表时间:
2023-05-06
期刊:
NEUROSCIENCE LETTERS
影响因子:
2.5
作者:
[Chen,Long, Wang,Lu, Chen,Guo-Jun]
通讯作者:
Chen,Guo-Jun
DOI:
10.1111/jnc.15184
发表时间:
2020-09-30
期刊:
JOURNAL OF NEUROCHEMISTRY
影响因子:
4.7
作者:
[Li, Kun-Yi, Xiang, Xiao-Jiao, Chen, Guo-Jun]
通讯作者:
Chen, Guo-Jun
DOI:
10.1016/j.gendis.2023.04.037
发表时间:
2023
期刊:
Genes & Diseases
影响因子:
6.8
作者:
[Shiqi Xie, Xiaoyong Xie, Jing Tang, Biao Luo, Jian Chen, Qixin Wen, Jianrong Zhou, Guojun Chen]
通讯作者:
Guojun Chen
DOI:
10.1073/pnas.2220148120
发表时间:
2023-05-30
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子:
11.1
作者:
[Zhou, Gui-Feng, Tang, Jing, Ma, Yuan-Lin, Fu, Xian, Liu, Jun-Yan, Yang, Ren-Zhi, Zhang, Hong-Sheng, Cai, Xiang-Hai, Wang, Jing-Wen, Xie, Xiao-Yong, Song, Li, Luo, Biao, Chen, Jian, Chen, Long, Deng, Xiao-Juan, Chen, Guo-Jun]
通讯作者:
Chen, Guo-Jun
DOI:
10.1096/fj.202002461r
发表时间:
2021-05
期刊:
The FASEB Journal
影响因子:
--
作者:
[Bi-Rou Zhong;Gui-Feng Zhou;Li Song;Qi-Xin Wen;Xiao-juan Deng;Yuanlin Ma;Li-Tian Hu;Guo-Jun Chen]
通讯作者:
Bi-Rou Zhong;Gui-Feng Zhou;Li Song;Qi-Xin Wen;Xiao-juan Deng;Yuanlin Ma;Li-Tian Hu;Guo-Jun Chen
共 10 条
ARL6IP1参与小分子Conophylline对阿尔茨海默病的病理机制调控
-
批准号:82271461
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈国俊
-
依托单位:
A-beta损害nAChR在中间神经元内介导的兴奋性机制研究
-
批准号:81171197
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:陈国俊
-
依托单位:
国内基金
海外基金